Loading stock data…
Waters Corporation (WAT)
$368.87-5.54 (-1.48%)
Market ClosedLast close Jun 29
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Waters Corporation in the Healthcare sector is trading at $368.87 with a market capitalization of $37.3B. Wall Street consensus targets $401.78 (23 analysts), implying a +8.9% move over the next 12 months. The stock is currently 11% below its 52-week high of $414.15, remaining 6.4% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +8.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.27B↑ | $932.36M↑ | $799.89M↑ | $771.33M↑ | $662.00M |
| Gross Profit | $588.00M↑ | $569.50M↑ | $472.08M↑ | $449.93M↑ | $385.00M |
| Operating Income | -$47.00M↓ | $270.52M↑ | $192.11M↑ | $188.21M↑ | $152.00M |
| Net Income | -$72.00M↓ | $225.21M↑ | $148.92M↑ | $147.11M↑ | $121.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spect...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$37.29B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
48.38
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.14
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.94%
Volume
Today's trading volume
724,061
Recent News
Waters Corporation (WAT): Buy, Sell, or Hold Post Q1 Earnings?
Over the last six months, Waters Corporation’s shares have sunk to $357.08, producing a disappointing 7.2% loss - a stark contrast to the S&P 500’s 7.8% gain. This may have investors wondering how to approach the situation.
Waters Corporation Stock: Is WAT Underperforming the Health Care Sector?
Waters Corporation has lagged behind the broader health care sector over the past year, but analysts remain fairly bullish about its future prospects.
Waters Launches New Tools As Investors Weigh Biologics And Battery Upside
Waters Corporation (NYSE:WAT) has launched new analytical instrument platforms and workflow solutions, including BioResolve Peptide and GTxResolve Lipid Columns. The company also introduced new high-performance mass spectrometry systems that support biopharmaceutical development, multiomics research, and battery safety testing. These products are aimed at improving characterization of complex biologics and lipids, speeding structural omics analysis, advancing imaging for translational...
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 6.4%, nearly mirroring the S&P 500.
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls